MedTrace Logo

Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

NCT03382717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-03-15

No results posted yet for this study

Summary

This study evaluates the effect of the medical device "Excilor® Forte" in the treatment of toenail onychomycosis. Half of the participants will receive the tested product and the other half will receive a comparator (Amorolfin 5%). Patients will be followed during 6 months.

Conditions

  • Onychomycosis of Toenail

Interventions

DEVICE

Excilor Forte

1 application per day during 6 months

DRUG

Loceryl 5%

1 application per week during 6 months

Sponsors & Collaborators

  • Oystershell NV

    lead INDUSTRY

Principal Investigators

  • Nejib Doss, MD · Principal Instruction military hospital of Tunis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-26
Primary Completion
2017-08-26
Completion
2017-08-26

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382717 on ClinicalTrials.gov